MeiraGTx Holdings PLC MGTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/13/24 EDT
5.14quote price arrow up+0.07 (+1.38%)
Volume
77,126
52 week range
3.49 - 8.35
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close5.14
  • 52 Week High8.35
  • 52 Week High Date06/09/23
  • 52 Week Low3.49
  • 52 Week Low Date10/25/23

Key Stats

  • Market Cap330.536M
  • Shares Out64.31M
  • 10 Day Average Volume0.12M
  • Dividend-
  • Dividend Yield-
  • Beta1.43
  • YTD % Change-26.78

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close5.14
  • 52 Week High8.35
  • 52 Week High Date06/09/23
  • 52 Week Low3.49
  • 52 Week Low Date10/25/23
  • Market Cap330.536M
  • Shares Out64.31M
  • 10 Day Average Volume0.12M
  • Dividend-
  • Dividend Yield-
  • Beta1.43
  • YTD % Change-26.78

RATIOS/PROFITABILITY

  • EPS (TTM)-1.27
  • P/E (TTM)-4.04
  • Fwd P/E (NTM)-2.52
  • EBITDA (TTM)-138.16M
  • ROE (TTM)-69.92%
  • Revenue (TTM)11.38M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-651.19%
  • Debt To Equity (MRQ)59.47%

EVENTS

  • Earnings Date08/08/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On MeiraGTx Holdings PLC

 

Profile

MORE
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage gene therapy company. The Company is focused on three distinct areas of unmet medical need: ocular diseases, including inherited retinal diseases (IRDs), as well as large degenerative ocular diseases, severe forms of xerostomia and neurodegenerative diseases. Its product pipeline includes botaretigene sparoparvovec or bota-vec, for the treatment of X-linked retinitis pigmentosa related to mutations in the...
Keith Harris Ph.D.
Independent Chairman of the Board
Alexandria Forbes Ph.D.
President, Chief Executive Officer, Director
Richard Giroux
Chief Financial Officer, Chief Operating Officer
Robert Wollin J.D.
General Counsel, Secretary
Address
450 E 29th St Fl 15
New York, NY
10016-8367
United States

Top Peers

SYMBOLLASTCHG%CHG
VRCA
Verrica Pharmaceuticals Inc
9.56+1.56+19.50%
OCGN
Ocugen Inc
1.81+0.22+13.84%
AVXL
Anavex Life Sciences Corp
3.99+0.18+4.72%
XOMA
XOMA Corp
25.77+0.33+1.30%
PGEN
Precigen Inc
1.35+0.08+6.30%